top of page

AKBA

Akebia Therapeutics Inc.

$0.64

chg

-0.05 (-6.80%)

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

0.241

52 wk hi

2.6

Cash

$174.6M

Burn Rate (Qtr)

$21.6M

Mkt Cap

$117.7m

Avg Volume

1,807,862

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by

AKBA

BPIQ_Logo_RGB-01.jpg

Company Profile

Since our founding in 2007, we’ve put tenacity and innovation to work to develop novel therapeutics that have the potential to set new standards of care for people living with kidney disease. We have emerged as a leader with deep roots in the renal community. Today, we are a fully integrated biopharmaceutical company with both an experienced nephrology-focused commercial team and a robust development organization.

Recent Posts

See what the community is saying - click to see full post.

bottom of page